showed that emodin can significantly regulate the expression of cell cycle-related proteins (such as CDK2, CDK4, CDK6) in hepatocellular carcinoma cells and normal hepatocytes (Lin et al., 2017; Li et al., 2022). This evidence concerns the gene CDK4 and hepatocellular carcinoma.